Search Results
36 items found for "Debbie L. Hay"
- Pharmacological Properties and Function of PxOctβ3 Octopamine Receptor in Plutella xylostella (L.)
September 2022 "The diamondback moth (Plutella xylostella) is one of the most destructive lepidopteran pests of cruciferous vegetables, and insights into regulation of its physiological processes contribute towards the development of new pesticides against it. Thus, we investigated the regulatory functions of its β-adrenergic-like octopamine receptor (PxOctβ3). The open reading frame (ORF) of PxOctβ3 was phylogenetically analyzed, and the levels of expression of the receptor mRNA were determined. This ORF was also cloned and expressed in HEK-293 cells. A series of octopamine receptor agonists and antagonists were tested against PxOctβ3. We showed that the receptor is a member of the Octβ3 protein family, and an analysis using quantitative PCR showed that it was expressed at all developmental stages of P. xylostella. Octopamine activated PxOctβ3, resulting in increased levels of intracellular cAMP. Furthermore, the agonists naphazoline, clonidine, 2-phenethylamine, and amitraz activated the PxOctβ3 receptor, and naphazoline was the most effective. Only metoclopramide and mianserin had significant antagonistic effects on PxOctβ3, whereas yohimbine, phentolamine, and chlorpromazine lacked obvious antagonistic effects. The injection of double-stranded RNA in an RNA interference assay indicated that PxOctβ3 regulates development in P. xylostella. This study demonstrated the pharmacological properties and functions of PxOctβ3 in P. xylostella, thus, providing a theoretical basis for the design of pesticides that target octopamine receptors." Read more at the source #DrGPCR #GPCR #IndustryNews
- 📰 GPCR Weekly News, April 24 to 30, 2023
Sakmar, Debbie L. Hay, Lukas Grätz, and more. Check out some of the latest GPCR discoveries below!
- Decoding GPCR Function: The Role of Mutagenesis in Rational Drug Discovery
., Yoo, L., Gao, Z. G., Irwin, J. J., Shoichet, B. K., & Jacobson, K. A. (2010). D., Muñoz, L. L., Gregory, K. J., White, P. J., Sexton, P. M., Christopoulos, A., & May, L.
- Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota..
Here, we show that the gut IEL GLP-1 receptor (GLP-1R) is not required for enteroendocrine L cell GLP These data reposition key roles of the L cell-gut IEL GLP-1R axis, revealing mechanisms linking GLP-1R
- An overview of the compartmentalized GPCR Signaling: Relevance and Implications
., Hunyady, L., Luttrell, L. M., & Lefkowitz, R. J. (2003). L. (2017). doi.org/10.1007/s11064-016-2026-6 Mendizabal-Zubiaga, J., Melser, S., Bénard, G., Ramos, A., Reguero, L. Z., Wilderman, A., Katakia, T., McCann, T., Yokouchi, H., Zhang, L., Corriden, R., Liu, D., Feigin, M
- From DNA day to GPCR genomics
L., Dohlman, H. G., Frielle, T., Bolanowski, M. A., Bennett, C. D., Rands, E., Diehl, R. C., Lundin, L. G., & Schiöth, H. B. (2003). B., Panova, O., Hilger, D., Casiraghi, M., He, F., Maul, L., Gmeiner, P., Kobilka, B.
- The integrin ligand SVEP1 regulates GPCR-mediated vasoconstriction via integrins α9β1 and α4β1
Several integrins directly modulate VSMC contraction by regulating calcium influx through L-type voltage-gated
- Decoding β-Arrestins: from Structure to function
electron-electron resonance (DEER) spectroscopy for high-resolution conformational state determination (Wingler, L. A., et al. 1997, Bohn, L. M. et al. 1999), while dual knockout is lethal (Schmid, C. L., & Bohn, L. conformational changes for the binding to the same GPCR to mediate differential regulatory effects (Haider
- 📰 GPCR Weekly News, March 18 to 24, 2024
transporters and their AlphaFold2 predicted water-soluble QTY variants and uncovering the natural mutations of L- >Q, I->T, F->Y and Q->L, T->I and Y->F Industry News Sosei Heptares Doses First Subject in Phase 1 Trial
- Neuronal Gα subunits required for the control of response to polystyrene nanoparticles in the ...
Neuronal Gα subunits required for the control of response to polystyrene nanoparticles in the range of μg/L In nematodes, exposure to PS-NPs (1-100 μg/L) significantly altered transcriptional expressions of some
- Extracellular signal-regulated kinases – a potential pathway for GPCR-targeted drug discovery
., Hunyady, L., Luttrell, L. M., & Lefkowitz, R. J. (2003).
- Profiling Immune Cell and Platelet Transcriptomes
A study published in Scientific Data by Arne Hansen et a l has introduced a sensitive method for detecting
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
mGlu5 receptor is activated by the main excitatory neurotransmitter of the nervous central system, L-glutamate
- Structure-Based Discovery of Negative Allosteric Modulators of the Metabotropic Glutamate Receptor 5
mGlu5 receptor is activated by the main excitatory neurotransmitter of the nervous central system, L-glutamate
- Transmembrane domains of GPCR dimers – a novel hot spot for drug discovery
Ji, et al. 2020; L. Wan, 2020). when mGluR2 dimers are inactive, switching to an interface mainly at TM6 when the receptor is active (L.
- PH-Binding Motif in PAR4 Oncogene: From Molecular Mechanism to Drug Design
Point mutations are in the C-tail of PAR4 PH-binding domain; F347 L and D349A, but not E346A, abrogate
- 📰 GPCR Weekly News, February 20 to 26, 2023
and dopamine D2 receptor is required for selective potentiation of dopamine D2 receptor function by L- disease-associated LPA6 missense mutants and a potential pharmacoperone therapy for autosomal recessive woolly hair
- 📰 GPCR Weekly Buzz: Exciting Schedule Shifts for Principles of Pharmacology I & II | August 12-18, 2024
cilium initiate SMOOTHENED-PKA signaling in the Hedgehog cascade Allatotropin (AT) related peptides L-ATRP
- 📰 GPCR Weekly News, December 4 to 10, 2023
Bryan L Roth study on Illuminating the understudied GPCR-ome Save the dates: February 8 - 29: Dr.
- 📰 GPCR Weekly News, March 6 to 12, 2023
Structural and Molecular Insights into GPCR Function Endogenous l- to d-amino acid residue isomerization
- 📰 GPCR Weekly News, May 20 to 26, 2024
kinases – a potential pathway for GPCR-targeted drug discovery Nicola J Smith, Lauren T May, and Natasha L
- VAMP2: a crucial player in the delivery of MOR to the synapse
Zhang, and L. Ma. 2008.
- Unlocking the Future of Medicine: Advancements in GPCR Research
Binding of Stalk-derived Peptide Agonists GPCR Binders, Drugs, and more In silico exploration of 4(α-l-rhamnosyloxy
- 📰 GPCR Weekly News, November 13 to 19, 2023
HDAC3 inhibition to activate autophagy in head kidney macrophages from turbot (Scophthalmus maximus L.
- 📰 GPCR Weekly News, March 13 to 19, 2023
Endogenous l- to d-amino acid residue isomerization modulates selectivity between distinct neuropeptide
- 📰 GPCR Weekly News, April 8 to 14, 2024
Katharina Grotsch, Bryan L Roth, Valery V Fokin et al. for their research on Virtual Screening of a
- Nanobodies: New Dimensions in GPCR Signaling Research
L., & Garcia, K. C. (2015). Structural biology.
- Finding needles in haystacks: Omass unveils pipeline aimed at tough-to-drug targets
November 2021 "Nov. 15, 2021 LONDON – There’s not yet proof of the pudding, but Omass Therapeutics Ltd.’s new structure-based technology has passed a key test, in enabling the discovery of orally available small molecules aimed at intractable and poorly drugged membrane and complex-bound protein targets. The targets, including G protein-coupled receptors (GPCRs), intracellular protein complexes and solute carriers, are relevant to immunology indications and rare diseases with high unmet need." Read more at the source #DrGPCR #GPCR #IndustryNews